Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000897069-24-002009
Filing Date
2024-10-22
Accepted
2024-10-22 20:44:01
Documents
2
Period of Report
2024-10-18

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 2264
2 ngpoa.htm EX-24 8198
  Complete submission text file 0000897069-24-002009.txt   12112
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE COURT WEST, SUITE B SAN DIEGO CA 92121
Business Address
Ng George K (Reporting) CIK: 0001638744 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37823 | Film No.: 241387606